Meet us at Antibody Engineering & Therapeutics or BioFit partnering events
Meet us in San Diego for Antibody Engineering & Therapeutics on 9th to 13th of December in booth #320.
Read more ›
Press release: Icosagen and AbCheck Announce Five-year Licensing Agreement Granting AbCheck Access to Icosagen’s Patented Mammalian Expression Technology
Icosagen and AbCheck Announce Five-year Licensing Agreement Granting AbCheck Access to Icosagen’s Patented Mammalian Expression Technology
Tartu (Estonia) and Plzen (Czech Republic) June 3,
2019 - Icosagen Cell Factory OÜ, a rapidly growing Estonian biotechnology
company focusing on protein production and in
vivo antibody discovery, and AbCheck s.r.o., a leader in providing antibody drug discovery,
engineering and optimization
services to the
biotech and pharmaceutical industry, today announced that they have
entered into a five-year licensing agreement granting AbCheck access to
Icosagen’s QMCF protein production technology. Under the terms of the
agreement, AbCheck will acquire rights to utilize Icosagen’s QMCF technology
platform for its commercial activities in antibody discovery.
“AbCheck’s and Icosagen’s partnership has a long history, and the
licensing agreement is a natural next step in our collaborative effort to bring
maximal benefits to our academic and industry partners and customers,” said Icosagen’s
CEO Prof. Mart Ustav.
“Adding Icosagen’s unique QMCF protein production technology to our
portfolio of versatile in vitro and in vivo technology solutions will allow
us to increase the efficiency of characterizing the large numbers of antibodies
we typically discover for our partners”, added AbCheck’s Managing Director Dr.
Volker Lang.
Read more ›
Meet us at PepTalk on 14th-18th of January in San Diego
Join Icosagen team at the 18th PepTalk in the booth #401. PepTalk: The Protein Science Week is one of the largest annual gatherings of protein science researchers in the world. Now, in its 18th year, PepTalk features renowned speakers from academia, biotech and pharma who bring global expertise and perspective to the forefront. The international delegation of over 1,300 participants convene for intensive learning and networking to discover new opportunities, apply alternative solutions, and develop promising partnerships.
Read more ›
Press release: Icosagen Cell Factory was awarded EUR 1.2 million
HybriFree recombinant antibody development article is published
Icosagen AS has incorporated a US subsidiary – Icosagen Technologies, Inc.
The Icosagen Cell Factory OÜ team is looking for a MARKETING SPECIALIST
QMCF Technology to be presented at the CHI's 14th Annual PepTalk conference in San Diego, California
Icosagen Cell Factory was titled the Best Entrepreneur of 2013
Icosagen Cell Factory presentation at Cell Line Development Conference